QuRetino Therapeutics Inc.
QuRetino is aiming to bring the next generation of acne vulgaris treatment with a highly selective more efficacious and safer topical drug
- Stage Product In Development
- Industry Biotechnology
- Location Palo Alto, CA, USA
- Currency USD
- Founded October 2012
- Employees 2
Company Summary
The mission of QuRetino is to successfully identify, rapidly develop, and bring to market with high sale potential new pharmaceutical products in specialized disease areas like Acne Vulgaris, by adding clinical POC. Our exit strategy is partnering, licensing or purchase by another company for further development to market.
Team
-
Marie JhinCMO
20 years working as a Board Certified dermatologist as well as 10 years Adjunct Clinical Instructor at Stanford University. Owner of Premier Dermatology in San Carlos and San Francisco. Published author and entrepreneur also current investor in the company.
-
Ferenc MakraFounder/President & CSO
Proven 26 years of experience in the pharmaceutical industry (Syva, Syntex and Roche) as a drug discovery scientist, research strategist, manager and inventor. Entrepreneur skilled at recognizing promising business opportunities in life science. Able to transform an idea into a concrete development strategy and company. Current investor in the company.
-
Roger WhitingBoard of Directors
Over 40 years of experience as a scientist, inventor and entrepreneur. Formally SVP at Syntex, Roche, co-Founder of RoxRo Pharma, CEO and President at Altos Therapeutics
-
Howard I MaibachSAB member
50 years of experience in dermatology, 40 years professor at UCSF, member of editorial board of more than 30 scientific journals, member of American Academy of Dermatology, published 1700 articles and textbooks
-
Macus A. Conant MD.Clinical Development
Over 40 years experience as a dermatologist and professor of UCSF, founder of several HIV clinics, formerly CMO of Presido Pharmaceutical & fm-SALUS Pharmaceutical
-
Vern Norvielcorporate lawyer &legal counsel
WSG&R partner, adjunct professor at UC Berkley, Advisory Board Member of Center for Science Technology, Board Member of Parkinson Institute
Advisors
-
Vern Norviel at Wilson SonsiniLawyerUnconfirmedTony H. Tarabay, CPAAccountantUnconfirmed
Previous Investors
-
Ferenc Makra (Founder)UnconfirmedDr. Marie Jhin (CMO)UnconfirmedMs. Ilona Merli (friend)Unconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.